Tvardi Therapeutics (TVRD) Assets Average: 2014-2017
Historic Assets Average for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to $113.0 million.
- Tvardi Therapeutics' Assets Average rose 31.26% to $113.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $113.0 million, marking a year-over-year increase of 31.26%. This contributed to the annual value of $87.4 million for FY2016, which is 4.73% up from last year.
- Tvardi Therapeutics' Assets Average amounted to $113.0 million in Q3 2017, which was up 40.15% from $80.6 million recorded in Q2 2017.
- In the past 5 years, Tvardi Therapeutics' Assets Average registered a high of $114.4 million during Q4 2015, and its lowest value of $44.8 million during Q1 2014.
- Moreover, its 3-year median value for Assets Average was $82.2 million (2015), whereas its average is $82.6 million.
- Its Assets Average has fluctuated over the past 5 years, first surged by 97.89% in 2016, then slumped by 49.68% in 2017.
- Tvardi Therapeutics' Assets Average (Quarterly) stood at $59.2 million in 2014, then surged by 93.39% to $114.4 million in 2015, then slumped by 37.07% to $72.0 million in 2016, then spiked by 31.26% to $113.0 million in 2017.
- Its last three reported values are $113.0 million in Q3 2017, $80.6 million for Q2 2017, and $53.6 million during Q1 2017.